Il trapianto di midollo osseo nei difetti congeniti dell'immunità.

Translated title of the contribution: Bone marrow transplantation in congenital defects of immunity

F. Porta, L. D. Notarangelo, F. Candotti, E. Mazzolari, A. Lanfranchi, A. G. Ugazio

Research output: Contribution to journalArticle

Abstract

BMT can cure several congenital immunological defects: if in these disease the engrafting is easier, the GVH reactions are more frequent and severe. The possibility to deplete from T lymphocyte the marrow before infusion, has overcame this difficulty. From 1968 183 BMT have been performed in Europe on patients with SCID (70 from HLA-identical donor, 113 from HLA-nonidentical donor). The survival after 2 years is 76% in the first group, and 56% in the second group (100 marrows have been T-depleted with different techniques). Strict isolation procedures before the transplant are very important to achieve good results. The possibility to treat different immunodeficiency With BMT are also discussed.

Original languageItalian
Pages (from-to)27-30
Number of pages4
JournalPediatria Medica e Chirurgica
Volume13
Issue number1
Publication statusPublished - Jan 1991

Fingerprint

Bone Marrow Transplantation
Immunity
Bone Marrow
Tissue Donors
T-Lymphocytes
Transplants
Survival

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Porta, F., Notarangelo, L. D., Candotti, F., Mazzolari, E., Lanfranchi, A., & Ugazio, A. G. (1991). Il trapianto di midollo osseo nei difetti congeniti dell'immunità. Pediatria Medica e Chirurgica, 13(1), 27-30.

Il trapianto di midollo osseo nei difetti congeniti dell'immunità. / Porta, F.; Notarangelo, L. D.; Candotti, F.; Mazzolari, E.; Lanfranchi, A.; Ugazio, A. G.

In: Pediatria Medica e Chirurgica, Vol. 13, No. 1, 01.1991, p. 27-30.

Research output: Contribution to journalArticle

Porta, F, Notarangelo, LD, Candotti, F, Mazzolari, E, Lanfranchi, A & Ugazio, AG 1991, 'Il trapianto di midollo osseo nei difetti congeniti dell'immunità.', Pediatria Medica e Chirurgica, vol. 13, no. 1, pp. 27-30.
Porta F, Notarangelo LD, Candotti F, Mazzolari E, Lanfranchi A, Ugazio AG. Il trapianto di midollo osseo nei difetti congeniti dell'immunità. Pediatria Medica e Chirurgica. 1991 Jan;13(1):27-30.
Porta, F. ; Notarangelo, L. D. ; Candotti, F. ; Mazzolari, E. ; Lanfranchi, A. ; Ugazio, A. G. / Il trapianto di midollo osseo nei difetti congeniti dell'immunità. In: Pediatria Medica e Chirurgica. 1991 ; Vol. 13, No. 1. pp. 27-30.
@article{d08bf68696f143cea70b5551f9fe627a,
title = "Il trapianto di midollo osseo nei difetti congeniti dell'immunit{\`a}.",
abstract = "BMT can cure several congenital immunological defects: if in these disease the engrafting is easier, the GVH reactions are more frequent and severe. The possibility to deplete from T lymphocyte the marrow before infusion, has overcame this difficulty. From 1968 183 BMT have been performed in Europe on patients with SCID (70 from HLA-identical donor, 113 from HLA-nonidentical donor). The survival after 2 years is 76{\%} in the first group, and 56{\%} in the second group (100 marrows have been T-depleted with different techniques). Strict isolation procedures before the transplant are very important to achieve good results. The possibility to treat different immunodeficiency With BMT are also discussed.",
author = "F. Porta and Notarangelo, {L. D.} and F. Candotti and E. Mazzolari and A. Lanfranchi and Ugazio, {A. G.}",
year = "1991",
month = "1",
language = "Italian",
volume = "13",
pages = "27--30",
journal = "Pediatria Medica e Chirurgica",
issn = "0391-5387",
publisher = "Vicenza Pediatria Medica E Chirurgica",
number = "1",

}

TY - JOUR

T1 - Il trapianto di midollo osseo nei difetti congeniti dell'immunità.

AU - Porta, F.

AU - Notarangelo, L. D.

AU - Candotti, F.

AU - Mazzolari, E.

AU - Lanfranchi, A.

AU - Ugazio, A. G.

PY - 1991/1

Y1 - 1991/1

N2 - BMT can cure several congenital immunological defects: if in these disease the engrafting is easier, the GVH reactions are more frequent and severe. The possibility to deplete from T lymphocyte the marrow before infusion, has overcame this difficulty. From 1968 183 BMT have been performed in Europe on patients with SCID (70 from HLA-identical donor, 113 from HLA-nonidentical donor). The survival after 2 years is 76% in the first group, and 56% in the second group (100 marrows have been T-depleted with different techniques). Strict isolation procedures before the transplant are very important to achieve good results. The possibility to treat different immunodeficiency With BMT are also discussed.

AB - BMT can cure several congenital immunological defects: if in these disease the engrafting is easier, the GVH reactions are more frequent and severe. The possibility to deplete from T lymphocyte the marrow before infusion, has overcame this difficulty. From 1968 183 BMT have been performed in Europe on patients with SCID (70 from HLA-identical donor, 113 from HLA-nonidentical donor). The survival after 2 years is 76% in the first group, and 56% in the second group (100 marrows have been T-depleted with different techniques). Strict isolation procedures before the transplant are very important to achieve good results. The possibility to treat different immunodeficiency With BMT are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026037991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026037991&partnerID=8YFLogxK

M3 - Articolo

C2 - 2052452

AN - SCOPUS:0026037991

VL - 13

SP - 27

EP - 30

JO - Pediatria Medica e Chirurgica

JF - Pediatria Medica e Chirurgica

SN - 0391-5387

IS - 1

ER -